TYROSINE

Molecular Excipient

Mwt. LogP HBD HBA PSA RB CSP3
181.0 0.3 3 3 84.0 3 0.22
CAS
60184
UNII
42HK56048U
SYNONYMS
ZINC ID(s)
Availability
Present in 100 ZINC catalogs

Known Active Genes

There has not been any activity reported at 10μM or less for this excipient (per ChEBML)

Clinical Trials

This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
Code Date Title Phase Status
NCT00268255 Gefitinib and Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer Phase 1/Phase 2 Withdrawn
NCT00227773 Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors Phase 2 Withdrawn
NCT02321293 2015-02-01 A Open-label Prospective Cohort Trial of Curcumin Plus Tyrosine Kinase Inhibitors (TKI) for EGFR -Mutant Advanced NSCLC Phase 1 Not Yet Recruiting
NCT02259049 2014-10-01 The Effects of L-Tyrosine on 24 Hour Blood Pressure and Heart Rate in Parkinson's Disease Phase 0 Recruiting
NCT02035501 2014-01-01 Treatment of TNNT1-Myopathy With L-Tyrosine. Phase 2 Enrolling By Invitation
NCT01998061 2013-12-01 Continuation of TKI With or Without Chemotherapy Beyond Gradual Progression Phase 2 Recruiting
NCT01676103 2012-09-01 The Effects of Supplementing Tyrosine on Blood Pressure in Parkinson's Disease Phase 1/Phase 2 Completed
NCT01460498 2012-08-01 Azacitidine (AZA) in Minimal Residual Disease (MRD) Chronic Myeloid Leukemia (CML) Phase 1/Phase 2 Active, Not Recruiting
NCT01259544 2009-01-01 BreathID® Test: A Non-invasive Modality to Detect Pancreatic Exocrine Insufficiency Phase 2 Completed
NCT00390364 2006-10-01 Everolimus in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Previous Therapy Phase 2 Terminated
NCT00258297 2004-04-01 Gefitinib in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer That Can Be Removed By Surgery Phase 2 Terminated
NCT00204295 2004-01-01 Study on Amino Acid Uptake in Brain Tumors Phase 2 Active, Not Recruiting
NCT00047788 2002-10-01 Efficacy Study of ZD6474 to Treat Multiple Myeloma Cancer Phase 2 Completed
NCT00302289 2000-01-01 B181: Stimulation of Thermogenesis by Bio-Active Food Ingredients Phase 1 Completed
NCT00000322 1997-04-01 Tyrosine for Methamphetamine Dependence - 1 Phase 2 Completed

(Browse) Purchasable Analogs in ZINC

Dosages

Route Formulation Per Unit Dose
Iv(infusion) Injection 3.4%

More Information

Usage Over Time

Comments